Characterization of pDNA-TMC Nanoparticle Interaction and Stability

Johanna Poecheim, Viorica Patrulea, Christian Reichert

  • 1Department of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, 1211 Geneva, Switzerland. gerrit.borchard@unige.ch.

Current Drug Delivery
|December 8, 2015
PubMed
Summary

N-trimethyl chitosan and chondroitin sulfate (TMC) nanoparticles effectively stabilize plasmid DNA (pDNA) for vaccine formulation. These cationic nanoparticles can be freeze-dried with sucrose for long-term storage, preserving DNA integrity.